A predictive model for efavirenz dosing

Affiliations

Comment

Chad Brown et al. Pharmacogenomics. 2012 Jan.

. 2012 Jan;13(2):137-8.

doi: 10.2217/pgs.11.158.

¹ Bioinformatics Research Center, Department of Statistics, North Carolina State University, Raleigh, NC 27695, USA.

No abstract available

Comment on

Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.
Sánchez A, Cabrera S, Santos D, Valverde MP, Fuertes A, Domínguez-Gil A, García MJ; Tormes Group. Sánchez A, et al. Antimicrob Agents Chemother. 2011 Nov;55(11):5314-24. doi: 10.1128/AAC.00194-11. Epub 2011 Sep 6. Antimicrob Agents Chemother. 2011. PMID: 21896912 Free PMC article. Clinical Trial.